MedTrace Logo

Remote Exercise Program Delivery Using a Mobile Application for Pulmonary Arterial Hypertension

NCT04559516 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-11-07

No results posted yet for this study

Summary

This study will determine the feasibility of a mobile application-based home exercise rehabilitation program for patients with pulmonary hypertension.

Conditions

  • Pulmonary Hypertension

Interventions

BEHAVIORAL

Exercise Intervention

The Ethica mobile app will provide a daily alert accompanied by a short educational statement about PAH, disease self-management tips, dietary and nutritional advice, goal setting, and a motivational statement to encourage patients. Participation with each session will be assessed by a mobile app-embedded survey administered at the end of the day. Patients will be presented with weekly alerts to complete validated patient-reported quality of life questionnaires using the EmPHasis-10 and the Living with Pulmonary Hypertension Questionnaire, as well as the PRAISE self-efficacy score for pulmonary rehabilitation. The app will also ask patients to report their WHO/NYHA functional class every week. Using in-app buttons, participants can log adverse events associated with each exercise session.

BEHAVIORAL

Standard Care

Participants will be provided usual care administered at the PH clinic at the University of Calgary and no supervised exercise session will be performed.

Sponsors & Collaborators

  • University of Saskatchewan

    collaborator OTHER

  • University of Calgary

    lead OTHER

Principal Investigators

  • Jason Weatherald, MD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-03
Primary Completion
2022-11-03
Completion
2022-11-03

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04559516 on ClinicalTrials.gov